Q1 2021 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-05-13 | ||||||
REV |
Q4 2020 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.390 | -0.740 | -0.3500 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
Ticker | Company | Price | Change | Chg % | Mkt Cap | |
---|---|---|---|---|---|---|
PSTV | Plus Therapeutics | 2.80 | 0.57 | 25.56% | 25.7M |
You can purchase shares of Plus Therapeutics (NASDAQ: PSTV) through any online brokerage.
Other companies in Plus Therapeutics’s space includes: Immuron (NASDAQ:IMRN), Anchiano Therapeutics (NASDAQ:ANCN) and Histogen (NASDAQ:HSTO).
The latest price target for Plus Therapeutics (NASDAQ: PSTV) was reported by HC Wainwright & Co. on 2021-02-11. The analyst firm set a price target for 7.00 expecting PSTV to rise to within 12 months (a possible 150.00% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Plus Therapeutics (NASDAQ: PSTV) is $2.8 last updated Fri Mar 05 2021 21:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Plus Therapeutics.
There is no upcoming split for Plus Therapeutics.